Professional Documents
Culture Documents
Pe Disease Report
Pe Disease Report
Pulmonary Embolism
Shawnee Payne
Lifespan II
what deep vein thrombosis is, as they are interconnected. It is also important to know about the
A deep vein thrombosis, also referred to as a DVT, is a clot of blood formed deep in the
vein. It most often occurs in the legs, but can occur in other extremities as well. There are a
number of different causes, but are most commonly due to slowed or blocked blood flow. DVT’s
can result from things such as an injury, excessive inflammation, or infection. The blocked or
slowed blood coagulates in the veins, and becomes lodged within the walls then a clot forms.
DVT’s cause various issues when lodged within the vascular system, but can also be life
threatening if they break off and form a pulmonary embolism. These emboli are dangerous
because they break off and travel back up the body, where they get caught in the small vessels of
the lungs and cut off blood flow (John Hopkins Medicine, 2021). Many signs and symptoms may
or may not arise, which will be discussed later, and can sometimes cause death. These are the
most common types of pulmonary embolisms as they occur in about 80% of patients with DVT,
although they may not always stem from a deep vein thrombosis.
Other types of pulmonary embolisms can include a fat embolism that occurs when small
pieces of fat get caught in blood vessels and cause blockages. These often occur because of
trauma such as orthopedic surgery, bone breaks or fractures, and even liposuction. Common
causes such as those release little pieces of fat which then travel through the vascular system and
get trapped in the smaller blood vessels such as the capillaries of the lungs. Fat embolisms
Pulmonary embolisms may go unnoticed in some cases but may present various signs and
symptoms in others. Some of the most common symptoms of a PE include shortness of breath,
tachypnea, tachycardia, chest pain, coughing up blood, lightheadedness, dizziness, fainting, and
blue lips or nails (John Hopkins Medicine, 2021). Most of which are due to the emboli getting
caught in the capillaries of the lungs and inhibiting proper blood flow and oxygenation to the rest
of the body.
Fat embolisms may present with other signs and symptoms such as tachypnea,
tachycardia, change in mental status, agitation, or a petechial rash. Petechiae are small red spots
that may appear all over the body. They are thought to be caused by post obstructive hemorrhage
that causes damage to the capillaries . They are commonly found on the conjunctiva, oral
Diagnostic Testing
There is not one single test that confirms the presence or absence of a pulmonary
embolism, instead it is more reasonable to conduct multiple tests in order to rule out or rule in
what the cause may be. The most common methods of diagnosis for a pulmonary embolism
D-dimer is used to rule out other speculated causes. This test takes a blood sample and
checks for issues with blood clotting. It works by measuring a protein that is released by the
body when a blood clot dissolves. A positive result means your body may be making clots. A
CTPA (CT Pulmonary Angiogram) is a test that looks for blood clots in the vessels within the
4
lungs. Dye is injected into the vascular system and will show up on scans as a bright white area.
This test is contraindicated in patients that are allergic to iodine. A V/Q scan is another kind of
test that is used to diagnose a pulmonary embolism. It stands for a ventilation/perfusion scan. A
small amount of radioactive tracer is used and it shows how well or how poor circulation of air
and blood is within the patient's lungs. It also tracks where in the body blood is flowing to. If the
ventilation and perfusion scans don't match, it may be indicative of a pulmonary embolism
(Kline, 2000). X-Rays are another common test used. They may not be able to detect if a
pulmonary embolism exists, but rule out other possible concerns with similar symptoms.
Treatments
medications help prevent any additional blood clots from forming and help prevent any existing
clots from getting larger. An example of this kind of treatment would be Heparin or Warfarin.
These drugs should be taken with caution. One of the major side effects includes bleeding since
these drugs stop the blood from clotting. Thrombolytic medications are used to break down
existing clots. These work by activating plasminogen that breaks down fibrin blood clots. (Baig,
2022) Taking thrombolytic medication should also be used with caution as they interfere with
coagulation and increase risk of bleeding. The lengths of treatment depends on the underlying
Surgery is another option for treatment. Thrombectomies are surgical procedures where a
catheter is inserted into the blood vessels and used to thin or suction out blood clots. This type of
surgery can also include the use of thrombolytic medication to assist in the removal. Pulmonary
5
thrombectomies work best when the clot is located in the larger blood vessels in the lungs such
stockings, and bedrest. Early ambulation is used in patients that are more stable and should not
be used in patients that have a significant PE. Ambulation is gradually increased and can help
strengthen the patient. It also helps prevent stasis of blood, therefore reducing the risk of clot
formation. Compression stockings help to reduce swelling and improve circulation in the legs.
The constant pressure is resistant to allowing blood to pool in the lower extremities and increases
circulation by assisting fluids back up towards the heart to then be recirculated. Bed rest is
important in those that actively have a DVT and in the prevention of it breaking off and forming
an emboli. Best rest is usually used in combination with anticoagulants or thrombolytics to break
Prevention
PE is the third most common cause of hospital related deaths, but it is preventable.
cessation of smoking, frequent exercise, avoid sitting for long periods of time or crossing legs,
staying hydrated, keeping a healthy weight and maintaining a healthy diet (John Hopkins
Medicine, 2021). All of these things are important for helping to maintain adequate perfusion
and movement of blood throughout the body. Before surgeries, doctors may prescribe
anticoagulants to patients that are at higher risk of clotting in order to help prevent blood clots
from forming.
6
Prognosis
Prognosis of a pulmonary embolism depends on the situation and may vary. Although
pulmonary embolisms may pose a huge risk and can be life threatening, the majority of patients
survive if diagnosed and treated promptly. Patients with a PE are at highest risk in the first week
of occurrence (Eichinger, 2004). Some early events that may occur include shock, stroke,
worsening oxygenation, respiratory failure, and pneumonia. Later events include death,
Pulmonary embolisms occur when circulation in the body is poor or inhibited which
leads to the formation of a clot. This clot can break off from the vessel walls and travel to the
lungs. Patients with a PE may or may not experience symptoms. It is important to seek early
diagnosis and intervention, as PE may be fatal. The most common tests used include the
D-Dimer, CTPA, and V/Q scan. Treatment options vary depending on the situation but most
disease and is prevented by maintaining proper cardio and pulmonary function, as well as
healthy lifestyle changes. Patients experiencing PE symptoms should seek help immediately. The
more time that passes without intervention, the risk of complications and death increases.
7
References
Eichinger S, Weltermann A, Minar E, et al. (2004) Symptomatic Pulmonary Embolism and the
risk of recurrent venous thromboembolism. Arch Intern Med. 164(1) 92–96.
doi:10.1001/archinte.164.1.92 (Level V)
Johns Hopkins Medicine. (2021). Pulmonary Embolism . Health conditions and diseases.
https://www.hopkinsmedicine.org/health/conditions-and-diseases/pulmonary-embolism
Kline, J., Johns, K., Colucciello, S., & Israel, E. (2000) New diagnostic tests for pulmonary
embolism. Annals of emergency medicine. 35(2) 168-180
https://doi.org/10.1016/S0196-0644(00)70137-5. (Level 1)
Kwiatt, M. E., & Seamon, M. J. (2013). Fat embolism syndrome. International journal of critical
illness and injury science, 3(1), 64–68. https://doi.org/10.4103/2229-5151.109426